格雷斯

What if your wood, industrial and architectural coatings could do more? Connect with us next week at #ECS2025, and let's talk about it. Our team will be at stand #326 in Hall 3, and we've got two must-see sessions lined up on the product presentations stage: ?? March 25 | 10:30 AM – Dr. Alexander Kr?ger dives into the benefits of colloidal silica for architectural paints. ?? March 27 | 12:10 PM – Dr. Michael Bulanov breaks down RadCure matting solutions for achieving gloss control and clarity. We can’t wait to see you there. Stop by our booth or schedule a meeting here: https://lnkd.in/dcGhdyUW #Coatings #ArchitecturalPaints #UVCoatings #MaterialsScience

We are Standard Industries, a privately-held?global?industrial manufacturing company.?From roofing, waterproofing, and building materials to specialty chemicals,?our 20,000 employees around the world are?leveraging technology to innovate?across?the?industries?we operate in. Watch?to learn more.

Over the past 15+ years, iron contamination in FCCUs has increased by >25%, driven by the rise in processing of high-iron feedstocks like shale oil. Left unchecked, iron poisoning reduces catalyst effectiveness and compromises unit performance. We’ve done the research, backed by extensive benchmarking, laboratory evaluations, and protocol enhancements. Now we introduce a three-pronged approach to mitigating iron risks and unveil our breakthrough research protocol, providing data-driven solutions for more efficient and reliable operations. Download now for proven methods for tackling iron contamination: https://lnkd.in/dGKkfS7u #Refining #FCC #CatalystTechnology #IronTolerance

Standard Industries was a proud partner of this year’s #CERAWeek, an annual conference that brings together leaders across the energy sector. Employees from Standard and our operating companies including W. R. Grace and GAF Energy were in Houston for the week-long event, engaging in insightful discussions on the future of energy.

APIs don’t make themselves, and neither do strong supply chains. For pharmaceutical companies developing new active pharmaceutical ingredients (APIs), a secure and integrated supply chain helps keep production on track. ?? That’s why choosing the right manufacturing partner matters. A U.S.-based network with in-house regulatory starting materials (RSMs) can keep production reliable and built for scale. So how does that work in practice? ?? Brian Graves, Global Business Manager, Fine Chemicals, and Robert Hughes, Research Fellow, break down our process in this video. #Pharmaceuticals #Biotechnology #Manufacturing #SupplyChainManagement

Refiners know opportunity when they see it. Processing heavier, lower-cost feedstocks can unlock serious value, but only if your FCC unit can handle the challenge. High-metal crudes bring higher coke yields, more hydrogen production, and operating constraints that can cut into profitability. FUSION? catalyst is designed specifically for resid conversion. By combining two advanced technologies into a novel matrix-binding system, it can help refiners push past limitations and maximize their FCC potential. It’s not theory. The technology has been commercially proven in applications in different parts of the world. Process heavier crudes with confidence. Learn more here: https://lnkd.in/dNcdSQyE #FCC #Refining #Catalysts

Reactor downtime cutting into your polypropylene production? Polypropylene producers may experience reactor operability issues due to fouling and fines, which result in reactor downtime. CONSISTA? donor technology can prevent fouling and fines, by producing uniform resin particles that translate to smoother operations that maintain quality and efficiency. Swipe through our carousel to get a more in-depth look at how our CONSISTA? donor technology make smooth operations using UNIPOL? PP process technology: https://lnkd.in/dKDVZHNR #Polypropylene #Manufacturing #Catalysts

The average drug development timeline is still 10+ years. But, with the advancement and application of AI and ML, we could see a material impact on the time it takes to get a new drug to market in the future. In The Multifaceted Future of Pharma series from The Medicine Maker, Robert Hughes, Research Fellow at Grace, explores the different ways AI-driven advancements could accelerate the approval timeline. Read his insights here: https://lnkd.in/d7ctt-Tc #ArtificialIntelligence #Biotech #DrugDevelopment #Pharmaceuticals

We're hiring! Join W. R. Grace, a leader in specialty chemicals, as our Category Manager, Corporate Services, Indirect Procurement in Columbia, MD. Drive innovation and efficiency in our global operations while managing multi-million dollar spend.?You'll strategize cost optimization, develop supplier relationships, and create value in a dynamic, fast-paced environment!

A new chapter begins for our Manufacturing Leadership Program (MLP) participants! ?? Last month, we kicked off their 2025 journey by welcoming all 27 MLP participants to our Columbia headquarters for a three-day summit filled with hands-on learning and career development. They heard from Grace leaders, tackled real-world challenges in interactive sessions, and even toured our Curtis Bay, Maryland site. A huge thank you to everyone who made this event a success—our speakers, organizers, and most importantly, the participants. We can't wait to see how they grow throughout the program! If you’re interested in joining our 2026 cohort, applications will open in the fall. You can learn more here: https://lnkd.in/edD4nAaS #CareerDevelopment #Leadership #Manufacturing